Figure 1:
Overall survival in patients stratified at presentation according to uIFE and sFLC results, namely the presence of intact/fragmented Ig, abnormal serum free light chain ratio, and negative uIFE, revealed significantly shorter overall survival for the intact/fragmented Ig group (median OS: 1050 vs. 2010, vs. 2454 days, respectively, p< 0.048).

Overall survival in patients stratified at presentation according to uIFE and sFLC results, namely the presence of intact/fragmented Ig, abnormal serum free light chain ratio, and negative uIFE, revealed significantly shorter overall survival for the intact/fragmented Ig group (median OS: 1050 vs. 2010, vs. 2454 days, respectively, p< 0.048).

Close Modal

or Create an Account

Close Modal
Close Modal